This product is NOT intended to prevent, treat, or cure disease conditions
or to affect the structure or function of the body.
CJC1295 (modified) without DAC
PROPERTIES:
Molecular Formula: C152H252N44O42
Molecular Weight: 3368.7
Sequence of CJC1295 (modified) without DAC:
H-Tyr-(D)Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-
Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Sequence of CJC-1295:
H-Tyr-(D)Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-
Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH2
Status and Explanation:
CJC-1295, there is a Lysine "linker" with along with the Maleimodoproprionic acid (DAC complex). It is difficult to produce and expensive to make. The stability of real CJC-1295 is very weak, it’s not easy to keep or ship. As a result it could be cost-prohibitive to research extensively.
CJC1295 (modified) without DAC is stable enough and easy to be researched. The bioactivity is also remarkable. This research has VALUABLE SIGNIFICANCE.
Technical data of researched (modified) CJC-1295
Appearance: White Freeze-dried powder
HPLC-MS Purity: 99.60%
Endotoxin Level: Less than 1.0 EU/μg of modified CJC-1295 without DAC
Storage:
REFRIGERATE OR FREEZE UPON RECEIPT.
Keep refrigerated after reconstitution.
Allow 24 hours for the peptide to settle before beginning your research.
All products contain sodium chloride for dilution.
Freeze-dried powder can be stored at -20 degrees C for over a year. Reconstituted solution should be kept in the refrigerator at 2-8 degrees C and used as early as possible. Avoid multiple freeze-thaw cycles and exposure to frequent for lyopilized powder or reconstituted vials.
Research Profile:
Modified CJC-1295 (without DAC) is a tetrasubtituted peptide of 29 amino acid length and a long acting GHRH analog, primarily functioning as a growth hormone releasing hormone (GHRH) analog.
Various experiments have been conducted to test the effectiveness of modified CJC-1295 (without DAC) in vivo and the Journal of Clinical Endocrinology & Metabolism has reported dose-dependent increases in mean plasma GH concentrations by 2-10 fold for more than 6 days and increased IGF-1 concentrations 1.5-3 fold for 9-11 days.
The active portion of this GRF or GHRH peptide can be found as a 29 amino acid long peptide. Growth-hormone-releasing hormone (GHRH), also known as growth-hormone-releasing factor (GRF or GHRF) or somatocrinin, is a 44-amino acid peptide hormone produced in the hypothalamus by the arcuate nucleus. GHRH stimulates growth hormone (GH) secretion from the pituitary. GHRH is released in a pulsatile manner, stimulating pulsatile release of GH respectively.
This research profile is only for reference. Reviewers should make sure of the bioactivity, half-life or the length of the studies differences between real CJC-1295 and modified CJC-1295 in advance. |
